Synthesis, characterization and phytobiological evaluation of new 2-[4-(4-bromophenylsulfonyl)phenyl]- 4-methyloxazol-5(4h)-one and some new 5-aryl-2-[4-(4-bromophenylsulfonyl)phenyl]-4-methyloxazoles
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
769 8
Ultima descărcare din IBN:
2021-12-22 19:10
Căutarea după subiecte
similare conform CZU
615.322 (217)
Medicamentele potrivit originii lor (478)
SM ISO690:2012
APOSTOL, Theodora-Venera, SOCEA, Laura-Ileana, BARBUCEANU, Stefania-Felicia, SARAMET, Ioana, OLARU, Octavian-Tudorel, DRAGHICI, Constantin C.. Synthesis, characterization and phytobiological evaluation of new 2-[4-(4-bromophenylsulfonyl)phenyl]- 4-methyloxazol-5(4h)-one and some new 5-aryl-2-[4-(4-bromophenylsulfonyl)phenyl]-4-methyloxazoles . In: Revista Farmaceutică a Moldovei , 2014, nr. 3-4, p. 45. ISSN 1812-5077.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Revista Farmaceutică a Moldovei
Numărul 3-4 / 2014 / ISSN 1812-5077

Synthesis, characterization and phytobiological evaluation of new 2-[4-(4-bromophenylsulfonyl)phenyl]- 4-methyloxazol-5(4h)-one and some new 5-aryl-2-[4-(4-bromophenylsulfonyl)phenyl]-4-methyloxazoles
CZU: 615.322

Pag. 45-45

Apostol Theodora-Venera1, Socea Laura-Ileana1, Barbuceanu Stefania-Felicia1, Saramet Ioana1, Olaru Octavian-Tudorel1, Draghici Constantin C.2
 
1 University of Medicine and Pharmacy “Carol Davilla”, Bucharest,
2 "C.D. Nenitzescu" Centre of Organic Chemistry, Romanian Academy
 
 
Disponibil în IBN: 5 ianuarie 2016


Rezumat

Heterocyclic compounds containing 1,3-oxazol-5(4H)-one and 1,3-oxazole ring are important targets in synthetic and medicinal chemistry, because of their applications as potentially active compounds. Thus, some 1,3-oxazol-5(4H)-ones have been reported to present antimicrobial and antitumor activity. 1,3-Oxazoles are frequent substructures in various biologically active compounds used in therapeutics as anti-inflammatory (e.g. Oxaprozin, Romazarit, Ditazol, Isamoxole), analgesic (e.g. Oxaprozin), antibacterial, antifungal (e.g. Sulfamoxole, Sulfaguanole), muscle relaxant (e.g. Azumolene) drugs. Therefore, there is considerable interest to synthesize new 1,3-oxazole5(4H)-ones and 1,3-oxazoles which contain 4-(4-bromophenylsulfonyl) phenyl moiety in 2 position with a hope to obtain potent biologically active compounds. The plant growth regulatory effects of the new compounds were examined.

Dublin Core Export

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'>
<dc:creator>Apostol, T.</dc:creator>
<dc:creator>Socea, L.</dc:creator>
<dc:creator>Barbuceanu, S.</dc:creator>
<dc:creator>Saramet, I.</dc:creator>
<dc:creator>Olaru, O.</dc:creator>
<dc:creator>Draghici, C.</dc:creator>
<dc:date>2014-12-11</dc:date>
<dc:description xml:lang='en'>Heterocyclic compounds containing 1,3-oxazol-5(4H)-one and 1,3-oxazole ring are important targets in synthetic and medicinal chemistry, because of their applications as potentially active compounds. Thus, some 1,3-oxazol-5(4H)-ones have been reported to present antimicrobial and antitumor activity. 1,3-Oxazoles are frequent substructures in various biologically active compounds used in therapeutics as anti-inflammatory (e.g. Oxaprozin, Romazarit, Ditazol, Isamoxole), analgesic (e.g. Oxaprozin), antibacterial, antifungal (e.g. Sulfamoxole, Sulfaguanole), muscle relaxant (e.g. Azumolene) drugs. Therefore, there is considerable interest to synthesize new 1,3-oxazole5(4H)-ones and 1,3-oxazoles which contain 4-(4-bromophenylsulfonyl) phenyl moiety in 2 position with a hope to obtain potent biologically active compounds. The plant growth regulatory effects of the new compounds were examined. </dc:description>
<dc:source>Revista Farmaceutică a Moldovei   (3-4) 45-45</dc:source>
<dc:title>Synthesis, characterization and phytobiological evaluation of new 2-[4-(4-bromophenylsulfonyl)phenyl]-
4-methyloxazol-5(4h)-one and some new 5-aryl-2-[4-(4-bromophenylsulfonyl)phenyl]-4-methyloxazoles
</dc:title>
<dc:type>info:eu-repo/semantics/article</dc:type>
</oai_dc:dc>